This document is an excerpt from the EUR-Lex website
Document 62013TN0583
Case T-583/13: Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission
Case T-583/13: Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission
Case T-583/13: Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission
OJ C 377, 21.12.2013, p. 19–19
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
21.12.2013 |
EN |
Official Journal of the European Union |
C 377/19 |
Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission
(Case T-583/13)
2013/C 377/43
Language of the case: English
Parties
Applicant: Shire Pharmaceutical Contracts (Hampshire, United Kingdom) (represented by: K. Bacon, Barrister, M. Utges Manley and M. Vickers, Solicitors)
Defendant: European Commission
Form of order sought
The applicant claims that the Court should:
|
— |
Annul the decision contained in the letter of the European Commission dated 2 September 2013, confirmed by the letter dated 18 October 2013, refusing eligibility for a reward for a voluntary pediatric investigation plan under Article 37 of Regulation (EC) No 1901/2006 (1); and |
|
— |
Order the defendant to bear the applicant’s costs. |
Pleas in law and main arguments
In support of the action, the applicant relies on two pleas in law.
|
1. |
First plea in law, alleging that the contested decision is vitiated by fundamental errors in law in the interpretation of Regulation (EC) No 1901/2006. |
|
2. |
Second plea in law, alleging a breach of the principle of legal certainty. |
(1) Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ 2006 L 378, p. 1)